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The sodium dependent bicarbonate transporter NCBE/NBCn2 is predominantly expressed
in the central nervous system (CNS). The highest protein concentrations are found in
the choroid plexus. The primary function of this integral plasma membrane transport
protein is to regulate intracellular neuronal pH and also probably to maintain the pH
homeostasis across the blood-cerebrospinal fluid barrier. NCBE is predicted to contain
at least 10 transmembrane helices. The N- and C- termini are both cytoplasmic, with a
large N-terminal domain (Nt-NCBE) and a relatively small C-terminal domain (Ct-NCBE).
The Nt-NCBE is likely to be involved in bicarbonate recognition and transport and
contains key areas of regulation involving pH sensing and protein-protein interactions.
Intrinsic disordered protein regions (IDPRs) are defined as protein regions having no
rigid three-dimensional structure under physiological conditions. They are believed to be
involved in signaling networks in which specific, low affinity, protein-protein interactions
play an important role. We predict that NCBE and other SoLute Carrier 4 (SLC4) family
members have a high level of intrinsic disorder in their cytoplasmic regions. To provide
biophysical evidence for the IDPRs predicted in Nt-NCBE, we produced pure (>99%),
recombinant Nt-NCBE using E. coli as the expression host. The protein was used to
perform differential scanning fluorescence spectroscopy (DSF), in order to search for small
molecules that would induce secondary or tertiary structure in the IDPRs. We expect this
to assist the development of selective pharmaceutical compounds against individual SLC4
family members. We have also determined a low resolution (4Å) X-ray crystal structure of
the N-terminal core domain. The N-terminal cytoplasmic domain (cdb3) of anion exchanger
1 (AE1) shares a similar fold with the N-terminal core domain of NCBE. Crystallization
conditions for the full-length N-terminal domain have been sought, but only the core
domain yields diffracting crystals.
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INTRODUCTION
In general, regulation of intra- and extracellular pH is cru-
cial for cellular function, because most metabolic enzymes have
optimal functionality within the narrow pH range of 6.8–7.4.
The main buffering system is based on carbonic acid and
bicarbonate, which effectively minimizes the impact of short-
term pH deviations (Cordat and Casey, 2009). Most mam-
malian cells depend on selective transport of bicarbonate across
the plasma membrane by specific integral membrane proteins
belonging to the SoLute Carrier 4 (SLC4) protein family. Ten
members of this family are involved in maintaining pH home-
ostasis (Parker and Boron, 2013). The SLC4 protein family
members are divided into three major functional classes; (i)
Na+-independent Cl−/HCO−3 exchangers, (ii) Na+, HCO
−
3 co-
transporters and, (iii) Na+ driven Cl−/HCO−3 exchangers (Boron
et al., 2009). The SLC4 family also exhibits differences associated
with electrogenic/electroneutral transport characteristics and stil-
bene derivative sensitivity. Stilbene derivatives, DIDS and SITS,
are the classic inhibitors that target the Sodium Bicarbonate
Cotransporter (NBC) family. Other potent inhibitors are diBAC
oxonol (Liu et al., 2007), S0859 (Ch’en et al., 2008), tenidap
and benzamil (Ducoudret et al., 2001). Members of NBC family
have earlier been highlighted as potential therapeutic targets of
ischemic reperfusion. Inhibition of the electrogenic Na+/HCO−3
cotransporter (NBCe1-b), found in the heart, showed a decrease
in ischemic injury (Khandoudi et al., 2001). The family may also
be targets to reduce tumor progression in, for example, breast
cancer (Boedtkjer et al., 2012). NCBE (NBCn2/SLC4A10) is an
electroneutral Na+-dependent HCO−3 transporter (Wang et al.,
2000; Giffard et al., 2003; Parker et al., 2008; Damkier et al., 2010)
found predominantly in the brain (Liu et al., 2010) with particu-
lar high expression levels found in the choroid plexus (Praetorius
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et al., 2004). NCBE is DIDS-sensitive (Wang et al., 2000). A
recent report indicates that NCBE is a potential neuronal drug
target. A study performed in mice showed that disruption of the
SLC4A10 gene could prevent fatal epileptic seizures (Jacobs et al.,
2008) indicating drugs counteracting this particular NBC might
be usable in anticonvulsive therapy. To date no unique inhibitor
of NCBE transport activity is known. The development of spe-
cific inhibitors against NCBE, or of any SLC4members in general,
would benefit our understanding of the sodium and bicarbon-
ate transport mechanism and perhaps lead to novel drugs that
selectively target specific SLC4 family members.
The general topology of the transporters includes a large
amino-terminal (Nt) cytoplasmic domain, a transmembrane
domain including extracellular regions of which certain loops can
be glycosylated and a smaller carboxy-terminal (Ct) cytoplasmic
domain (Figure 1). In general, very little structural data is avail-
able for members of this protein family. Two homology models
of the anion exchanger 1 (AE1) transmembrane domain based
on the E. coli chloride-proton channel (ClC) (Bonar et al., 2013)
and the uracil transporter (UraA) (Barneaud-Rocca et al., 2013)
have been proposed, although there is no significant similarity of
AE1 primary structure to these. Historically, the large N-terminal
cytoplasmic domain (Nt) has been the target for functional and
structural characterization. It is known to be involved in the
regulation of transport activity. For example an auto inhibitory
domain is found in NBCe1-B/C (McAlear et al., 2006; Lee et al.,
2012). Protein—protein andmetabolite-protein interactions have
also be reported, for example glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) with erythrocyte AE1 (Chu and Low, 2006)
and inositol-1,4,5-trisphosphate (IP3) receptors binding protein
released with IP3 (IRBIT) with NBCe1-B (Shirakabe et al., 2006).
However, knowledge of the molecular basis for NBC function and
FIGURE 1 | The general domain structure of a SLC4 bicarbonate
transporter represented as a dimer. The Transmembrane (TM) domain is
shown in green. Dimerization is driven by dimerization arms close to the Nt
core domains (blue) in the cytoplasm. Variable region 2 (VR2) is drawn as an
extended loop from the core domain. Variable region 1 (VR1) is shown as
an N- terminal extension from the core domain. The C- terminal region
often contains a small PDZ domain (Kennedy, 1995) (cyan). Glycosylations
are shown as black sticks.
regulation is still limited. The cytoplasmic domain of human AE1
(cdb3) has been crystallized and the structure determined at 2.6 Å
resolution. Only residues 55–356 out of the 379 residues available
in the crystallized construct were visible in the electron density.
The structure forms a dimer, with a dimerization arm formed by
residues 317–356. A central elongated β-sheet is present in both
monomers surrounded by several α-helices (Zhang et al., 2000).
The cytoplasmic Nt domain fromNBCe1-A, an electrogenic Na+,
HCO−3 co-transporter, has been expressed and purified in E. coli
(Gill and Boron, 2006), but the structure determination is prob-
lematic (Gill et al., 2013). The SLC4 family proteins are, like the
ClC channels, believed to be homodimers. Chemical cross-linking
followed by SDS-PAGE indicates that membrane bound full-
length NBCe1-A forms dimers and traces of tetramers (Kao et al.,
2008). AE1 is believed to form both dimers and tetramers (Jiang
et al., 2013). Nt-NBCe1-A is able to form monomers, dimers and
tetramers in solution (Gill, 2012). It has been observed that the
oligomeric state is pH dependent and it is postulated that con-
formational changes occur within the monomers (Zhang et al.,
2000; Gill, 2012). It is therefore possible that the activity of the
SLC4 family proteins is related to changes in the oligomeric state
and that this happens as a consequence of changes in pH.
Protein function is traditionally thought to depend primarily
on the chemical environment created by the tertiary structure of
the macromolecule, and it is believed that the composition of the
primary structure supports certain secondary and tertiary struc-
tures (or folds) of the macromolecule. In recent years, attention
has turned to proteins containing non-structured regions—and,
in particular, to the function of these regions. These intrinsically
disordered protein regions (IDPRs) (Uversky, 2013) are abun-
dant in protein sequences of all organisms, and the number of
IDPRs increases as the complexity of the organism increases.
In general, the highest percentage of the predicted disorder is
found in eukaryotes (Xue et al., 2012) probably because regula-
tion needs to be tighter and is intrinsically more complex than
in other domains of life. Experimental identification of IDPRs is
tedious and large scale analyses rely on in silico predictions from
the primary structures. Today disordered regions can be predicted
with between 80 and 90% accuracy (He et al., 2009). IDPRs are
especially common as mediators of protein–protein interactions.
Many are found in proteins related to signaling and are therefore
important in understanding diseases such as neurodegenerative
disease and cardiovascular disease (Metallo, 2010). For these rea-
sons they represent a class of high-value pharmaceutical targets
but due to their poorly characterized properties they have not yet
been investigated to any great extent.
In polarized epithelia, the SLC members can reside either in
the apical or in the basolateral plasma membranes depending on
the primary structure and perhaps the cellular membrane sort-
ing, or membrane protein retaining machineries. To date it is
unknown which specific intracellular motifs are involved in the
membrane targeting of the SLC4 proteins. Motifs in the Nt or
Ct most probably carry a signal for the polarized insertion of
the transporters into the plasma membrane (Toye et al., 2004),
but extracellular loop glycosylation or even NBC-binding adaptor
proteins may also control membrane targeting, as is the case for
the Na+, K+-ATPase (Mellman and Nelson, 2008).
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The function of the Nt cytoplasmic domain, in concert with
the transmembrane domain, has been studied in AE1 andNBCe1.
Unlike AE1 (Groves and Tanner, 1992), NBCe1 seems unable to
function without this domain (Espiritu et al., 2006;McAlear et al.,
2006). The structure of the link between the cytoplasmic domain
and transmembrane domain may therefore be very class specific.
Specifically, for NBCe1, a substrate channel formed by the Nt
cytoplasmic domain has been suggested (Chang et al., 2008). The
Nt cytoplasmic domain, located close to the membrane, consists
of two constant regions (CR1 and CR2) separated by variable
region 2 (VR2) (Boron et al., 2009). The core domain is N-
terminally flanked by variable region 1 [VR1 or Nt-appendage
(Parker and Boron, 2013)] and is conserved in all members of
the SLC4 family. In this report we have focused on VR1 and
VR2 and show that they are likely to be intrinsically disordered
in all the SLC4 family members, but do, however, share distinct
recognizable signatures. We believe it is this intrinsic disorder
that has prevented thorough structural characterization of the
cytoplasmic domain. However, we hypothesize that the intrinsi-
cally disordered regions found in VR1 and VR2 may be used as
specific drug targets to distinguish between the individual SLC4
members and that together they form a distinct structural “fin-
gerprint” for each individual SLC4 transporter.We have identified
buffer conditions and a purification protocol to produce pure
and monodispersed solutions of both the complete cytoplasmic
domain of NCBE and what we refer to as the core domain, with-
out VR1. We also present a novel screening approach, developed
to identify small interacting molecules. The screening procedure
is potentially applicable as an initial screen to identify leads tar-
geting the VR1 and/or the VR2 regions which are present in the
cytoplasmic domain of NCBE and other SLC4 members.
MATERIALS AND METHODS
CLONING AND EXPRESSION
The gene encoding SLC4A10 isoform 3 from Rattus norvegi-
cus (rb2NCBE) was purchased from GenScript. Primers were
designed for ligation independent cloning (LIC) into the pET-
46 Ek/LIC vector (Novagen) for the production of an N-terminal
hexa-histidine tagged fusion protein. For construct Nt-NCBE
residues 2–421 and the construct Nt-NCBE-D1 residues
96–396. A tobacco etch virus (TEV) protease recognition site was
included in the primer located between the hexa-histidine and
protein sequence of interest.
Nt-NCBE and Nt-NCBE-D1 were expressed in E. coli strain
Rosetta2 (Novagen) expressing seven additional tRNAs to com-
pensate for the codon bias in the mammalian gene during
prokaryotic expression. An O/N culture of 100mL LB media
with chloramphenicol (50μg/mL) and ampicillin (34μg/mL)
from a single colony of transformed Rosetta2 cells was made
for inoculation of fermentation in 1.5 l of LB media (antibiotics
added+1mL of polyethylene glycol). At optical density measured
at 600 nm (OD600) of 1.0, the media was cooled to 18◦C and
induced with 1mM (IPTG). The cells were harvested after 16 h
yielding∼10 g of wet-weight cells. Cell cultures were grown using
a LEX HT Bioreactor (Harbinger). Expression levels were visual-
ized by SDS-PAGE with samples taken before and after induction.
Protein identity was confirmed using tandemmass-spectrometry.
PROTEIN PURIFICATION
For each gram of frozen cell pellet 10mL lysis buffer (50mM
NaCl, 100mM Tris-HCl pH 8.0, 1 ug/mL DNAseI, 1mM PMSF,
1x EDTA-free inhibitor cocktail tablet (Roche), 5mM β-ME
and 40mM imidazole) was used for resuspension. Resuspended
cells were lysed by forcing the suspension three times through
high-pressure homogenizer (Emulsiflex C3, Avestin). Cell lysate
was kept on ice. The cell lysate was ultracentrifuged for 1 h at
200,000 g to remove cell debris and membrane fractions. The
cleared lysate was loaded onto a Ni-NTA column (GE) in equi-
libration buffer (50mM NaCl, 100mM Tris-HCl pH 8.0, 40mM
imidazole and 5mM β-ME) using an Äkta Prime FPLC system.
The column was washed with 10 column volumes (CV) of equi-
libration buffer. An additional wash with 10 CV of high-salt
buffer (500mM NaCl, 100mM Tris-HCl pH 8.0, 40mM imida-
zole and 5mM β-ME) was performed. The protein was released
with elution buffer (50mM NaCl, 100mM Tris-HCl pH 8.0,
200mM imidazole and 5mM β-ME). The elution peak fractions
were collected and checked by SDS-PAGE analysis. The concen-
tration of the eluted protein was measured using a NanoDrop
Spectrophotometer (Thermo Scientific). 1:50 molar ratio of GFP-
tagged TEV-protease was added and the suspension was dialyzed
O/N against dialysis buffer (50mM NaCl, 100mM Tris pH 8.0,
5mM β-ME and 40mM imidazole). To remove uncleaved protein
and the TEV protease, the suspension was passed over the pre-
equilibrated Ni-NTA column and the flow-through containing
the cleaved target protein was collected.
The protein was then concentrated using a 10 MWCO Viva
spin filter (GE Healthcare). The concentrated sample was loaded
on a Superdex 200 HiLoad 10/600 prep-grade column as a final
purification step and for determination of homogeneity using an
Äkta Purifier HPLC system. Fractions containing pure target pro-
tein were collected and kept at 4◦C for further analysis. Purity was
assessed using SDS-PAGE (Supplementary Figure S1).
CRYSTALLIZATION AND STRUCTURE DETERMINATION
Crystallization conditions were screened using commercially
available kits. Suitable crystals were only identified for the con-
struct NCBE-D1 in the condition 100mM potassium thio-
cyanate (KSCN) and 20% PEG3350. This condition produced
showers of crystals of limited size (50 × 50 × 50μm). Crystals
were flash cooled to 100K in the well solution supplemented
with 10% ethylene glycol. Diffraction data was collected at the
European Synchrotron Radiation Facility (ESRF) ID29 beam-
line. Data collection strategy was determined using iMOSFLM
(Battye et al., 2011) and the data were processed at the beamline
using XDS (Kabsch, 2010) and PHENIX (Adams et al., 2002). A
molecular replacement solution was found with the search model
for Nt-AE1 [PDB ID 1HYN, (Zhang et al., 2000)]. A homol-
ogy model of the NCBE-D1 based on 1HYN was created with
Modeler (Eswar et al., 2007) and used to perform rigid body
refinement against the experimental data. Data and refinement
statistics are collected in Supplementary Table S2.
DIFFERENTIAL SCANNING FLUORESCENCE (DSF)
Differential scanning fluorescence (DSF) measurements were car-
ried out using a 7900 HT Fast Real-Time PCR system (Applied
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Biosystems) using λex = 462 nm and λem = 569 nm (Hawe et al.,
2008). The protein stock was 1mg/mL and contained 100mM
NaCl, 20mM HEPES pH 7.2, and 0.5mM TCEP. A prescreening
of dye (Sypro Orange, Novagen) and protein was done in order
to find the best dye and protein concentration. This was found
to be 0.5 mg/mL protein and 100x Sypro Orange. Measurements
were carried out in 96 well plate format sealed to prevent evapo-
ration during experiment. Temperature increments of 1◦C/min
and a temperature range of 20–90◦C were used (Niesen et al.,
2007). Small molecules were supplied by the Silver Bullets Screen
(Hampton Research) and were diluted five-fold for use. Sypro
Orange was added as last component. Data treatment was per-
formed using MS Excel and GraphPad Prism 6. A data sheet
containing information on individual screen conditions, with
hit conditions highlighted, can be found in the Supplementary
Material.
PREDICTION OF DISORDER IN THE SLC4 FAMILY
Predictions of SLC4 protein disorder were made using the
PONDR-FIT metapredictor (Xue et al., 2010). The predictor is
the newest development of the PONDR (Predictors Of Natural
Disordered Regions) series and shows good accuracy. Query
sequences from human SLC4 family proteins were obtained from
the UNIPROT sequence database. All isoforms that have been
identified at the protein level were chosen for analysis. The aver-
age disorder of the whole family, subfamilies and individual
isoforms were calculated using GraphPad Prism 6.
RESULTS
CRYSTAL STRUCTURE OF N-TERMINAL NCBE CORE DOMAIN
A crystallization condition was identified for NCBE-D1, and the
crystal structure of the Nt-NCBE core domain was determined
at 4.0 Å resolution (Figure 2). At this resolution, ion binding
sites and side-chain positions cannot be resolved, only the back-
bone density is visible for residues 116–222 and 292–389 of the
NCBE-D1 construct containing residues 96–396. No electron
density is observed for variable region 2 (VR2). There is only
one single molecule in the asymmetric unit and no clear dimer
with a symmetry related molecule could be found in the crystal
lattice. Extensive crystallization screening was undertaken for Nt-
NCBE, but no crystallization condition has been identified even
after more than 5000 unique conditions have been screened. We
suspect that the intrinsic disorder of the Nt-NCBE construct may
have prevented crystallization.
PREDICTION OF DISORDERED REGIONS
A complete and large scale disorder prediction of the SLC4 family
was undertaken, as the crystallization trials and partial structure
indicated that large disordered regions could be present. All iso-
forms confirmed at protein level for SLC4A 1-5 and SLC4A 6-11
were analyzed. Selected isoforms are presented in Figure 3. The
transmembrane (TM) domain are the most conserved part of the
SLC4 family and sequences were aligned to the starting residue of
transmembrane helix 1 (TMH1). A high probability of disorder
was found for variable region 1 (VR1) of all SLC4 family proteins.
Likewise, a rather high probability of disorder was found for vari-
able region 2 [VR2, (Boron et al., 2009)] of the core domain and
for the flexible linker region occurring before the TMH1.
FIGURE 2 | The low resolution crystal structure of the cytoplasmic
N-terminal NCBE core domain. The lines show a C-α trace of the
molecular replacement model structure Nt-AE1 [1HYN, (Zhang et al., 2000)]
and the chicken wire shows the corresponding electron density contoured
at 1.5σ. Only density for constant regions 1 and 2 (D118-H222 and
K293-F389) is visible. No density was observed for variable region 2
(H223-K292) in the structure. The likely position of VR2 is shown as a red
line in the figure. Other regions not visible in the electron density were
residue ranges 96–117 and 390–396.
STABILIZATION OF DISORDERED REGION OF EXTREME N-TERMINUS
OF NCBE BY SMALL MOLECULES
DSF spectroscopy, commonly known as the thermofluor method,
is well documented for its use in determining optimal buffer
composition and compounds for the stabilization of proteins
(Ericsson et al., 2006; Vedadi et al., 2006). Briefly, a hydropho-
bic molecule (e.g., Sypro Orange) is added to the protein and,
optionally, a stabilizing compound. The solution is then heated—
as tertiary structure elements reach their melting point, they
fall apart and expose their hydrophobic cores which interact
with Sypro Orange. The increasing hydrophobic environment
enhances the quantum yield of the Sypro Orange chromophore
resulting in a dramatic increase of the fluorescent signal. The
method is therefore suited for measuring the possible induction
of a tertiary structure by small molecules and for high-throughput
screening (Pantoliano et al., 2001). Assuming that VR1 and VR2
of NCBE are IDPRs, we would like, if possible, to introduce some
tertiary structure to these regions for two reasons. Firstly, to iden-
tify compounds that would stabilize a more rigid fold and in turn
aid the crystallization process. Secondly, this technique might
result in a method for finding leads against pharmacologically
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FIGURE 3 | The prediction of disorder in the bicarbonate transporters of
the SLC4 family. Probability plots of the longest isoforms of SLC4A1-5 and
SLC4A7-10 are presented here. A total of 35 isoforms were analyzed. On
average, the highest probability of disorder is found in two regions of the
N-terminal cytoplasmic domain in the SLC4 family. A high level of disorder is
predicted for the variable regions 1 and 2 [VR1, VR2 (Boron et al., 2009)]. VR1
is highlighted in gray. This region was not visible in the Nt-AE1 structure and
no experimental structural information exists for it. VR2 is marked on the
plots and was modeled in the Nt-AE1 structure. In that structure the high
temperature factors and the random coil structure of the region (residues
166–213) support the disorder prediction. VR1 and VR2 are likely involved in
protein-protein interactions and regions could constitute a structural
“fingerprint” of each individual SLC4 transporter. UniProt accession codes for
presented plots are: AE1 (SLC4A 1, P02730), AE2-A (SLC4A 2, P04920-1),
AE3-B (SLC4A 3, P48751-1), NDCBE isoform 1 (SLC4A 8, Q2Y0W8-1), NCBE
isoform 1 (SLC4A 10, Q6U841-1), NBCn1-D (SLC4A 7, Q9Y6M7-7), AE4
isoform 1 (SLC4A 9, Q96Q91-1), NBCe2-a (SLC4A 5, Q9BY07-1), NBCe1-B
(SLC4A 4, Q9Y6R1-1).
interesting IDPRs. The 96 condition Silver Bullets combinato-
rial library (HR2-096, Hampton Research) provides∼400 unique
molecules for this purpose. Overlapping groups of similar com-
pounds are tested in each experiment. In general, a relatively high
initial fluorescence was observed for both NCBE constructs in the
absence of any screen molecules as well as in the presence of the
small molecules in the screen. A high initial fluorescence is often
seen for non-globular folded proteins and exposed hydrophobic
residues (Phillips and de la Pena, 2011) are anyway expected for
IDPRs. The control sample contained 100mM NaCl and 20mM
HEPES pH 6.8. This melting profile, exemplified by condition A5
in Figure 4A, is considered a non-hit melting profile as we do not
see a difference in overall profile from adding small molecules
to the protein. A significant change in profile was observed for
a number of conditions, for example by conditions A4, B4, and
D7 in Figure 4A (third, fourth, and fifth rows). The initial fluo-
rescence starts lower than in the control and the spectra indicate
a more complex transition model. We regarded such a profile as
indicating an interaction (a hit). Fluorescence backgrounds for
the dye and screen molecules alone were subtracted from the
spectra. From chemical overlap of conditions we can identify the
molecule that is likely to cause the effect (Figure 4B). In total eight
hit-profiles were identified from the screen (Figure 4C). Six of
the eight hit conditions containing 3,5-dinitrosalicylic acid. Three
of the eight hit conditions contained 4-aminobenzoic acid. We,
therefore, regard these molecules as candidates for further investi-
gation. The hit molecules were present in concentrations of 0.05%
w/v. The remaining spectra and chemical alignments are shown in
Supplementary Figure S3.
DISCUSSION
In general, the predicted levels of structural disorder are high
among SLC4 members in comparison to other eukaryotic mem-
brane proteins (Supplementary Figure S4), and therefore we
wish to further discuss the IDPRs of that family. The Na+-
K+ ATPase α-1 subunit (Supplementary Figure S4A) and the
Cystic Fibrosis Transmembrane conductance Regulator (CFTR)
(Supplementary Figure S4B) exhibit disorder profiles that show
short spans of disorder (e.g., loop regions) and no extended
disordered regions. When analyzing the crystal structure of the
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FIGURE 4 | Screening for interacting small molecules using the
thermofluor assay. (A) Control thermofluor spectra for each construct in the
absence of screen molecule showed high initial fluorescence commonly
associated with non-folded proteins (Phillips and de la Pena, 2011).
Thermofluor spectra of conditions A4, A5, B4, and D7 for both Nt-NCBE and
Nt-NCBE-D1 using the Silver Bullets screen: two general profiles were
observed. Condition A5 is representative of a “no interaction” profile similar
to the control. Conditions A4, B4, and D7 are profiles showing low initial
fluorescence and a multi-state melting profile indicating interaction between
the construct and the small molecule. We interpret these as weakly stabilized
structures. The general hit profiles were found for both Nt-NCBE and
Nt-NCBE-D1. The background subtracted relative fluorescence spectra are
shown. (B) Chemical overlap of the A4, B4, and D7 conditions. All conditions
suggest stabilization of the structure by one of the reactive compounds. The
conditions have a relatively high chemical similarity, with one compound in
common, namely 3,5-dinitrosalicylic acid. We note, however, that a
combinatorial effect could be involved in the stabilization of the target protein.
(C) Hits found in the 96 condition screen. Blue conditions show “no
interaction” profiles. Yellow represents “interaction” profiles.
3,5-dinitrosalicylic acid was present in six of eight of these conditions. The
identified compounds were not found in any conditions with “no interaction”
profiles.
Na+-K+ ATPase α-1 subunit an important loop region can
be identified in the disorder profile. The C-terminal of the
ClC-channel, however, (Supplementary Figure S4C), exhibits
extended disordered regions. This may relate directly to the ClC
channel ball-and-chain mechanism of regulation (Grunder et al.,
1992). A similar pattern to that of the ClC channel is found
for SLC26A6 (Supplementary Figure S4D), a transporter co-
occurring with CFTR (He et al., 2010). However, no evidence
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for a ball-and-chain mechanism for SLC26A6 has been reported.
NCBE isoform 1 and NBCn1-D (Figure 3) are shown to illustrate
the extent of the disordered regions found in the N-termini of
these proteins. The predicted degree of disorder seems to correlate
with the fact that many protein–protein interactions have been
established for the intracellular domains of SLC4 family proteins.
Description of a disordered “fingerprint” formed by VR1 and
VR2 of the N-terminal domain could enhance our understanding
of the nature of these interactions. We believe that this finger-
print will constitute a unique identifier for each family member.
Large variations in the predicted disorder levels are also pre-
dicted between isoforms of SLC4 family members (e.g., NBCn1),
and it seems that IDPRs may be present at sites of alternative
splicing.
IDPRs have previously been thought of as assemblies fluctu-
ating between a 3D structure, maybe statically disordered, and
a dynamically disordered state (Tsvetkov et al., 2008). Inhibitors
of these fluctuations could be other proteins, metal ions, small
molecules and post-translational modifications. The seeding of
secondary and tertiary structures can be measured using a range
of biophysical methods e.g., circular dichroism (CD), isother-
mal titration calorimetry (ITC), electron paramagnetic resonance
(EPR), and nuclear magnetic resonance (NMR). These are meth-
ods applied on a sample to sample basis and are not suited for
high-throughput screening (HTS). We show that the thermofluor
method provides a high-throughput tool for screening of tertiary
structure induction of multiple samples. This method of screen-
ing for small molecule interactions with IDPRs could potentially
be useful, in conjunction with orthogonal methods, as a first
approach to identify pharmacological leads. Our data do not
and cannot provide a molecular description of the interaction.
However, a lower initial relative fluorescence and a multi-state
transition, indicating a stabilization of the structure, provide a
selection criterion for HTS methods. Molecules identified by
chemical overlap of components of the screen will be candidates
for studies using serial methods (e.g., CD or ITC) for further
biophysical characterization of the interaction. As with all screen-
ing, false positives may occur and many pharmacologically active
molecules contain chemical moieties that can absorb light or flu-
oresce. For this reason we believe it is important to subtract the
spectra of the screen molecules and the dye. Fluorescence from
screen molecules may interfere with the spectrum if the emission
peak is close to that of the used dye. Absorbance may dampen the
signal, but we assume this effect is rather small due to the very
short light path in the experimental setup and the signal strength
usually gained from the dye.
The low-resolution crystal structure represents a first step
toward a structural understanding of NCBE. It is also the first
crystal structure of a SLC4 protein to be reported since 2006. We
show that the fold of the N-terminal core domain is conserved
between Nt-NCBE-D1 and Nt-AE1. In AE1 no electron density
was observed for residues 1–55 corresponding to VR1 in the crys-
tal structure. VR2 was modeled, but found to be devoid of sec-
ondary structure and to have high temperature factors, indicating
a large degree of mobility (Zhang et al., 2000) (Supplementary
Figure S5). The structure of the fingerprint region remains to be
determined, however, the nature of this region as presented in
this paper requires methods for studying protein dynamics rather
than a crystallographic approach.
Conservation of biological function is often translated directly
from sequence conservation at the level of the individual residues,
i.e., as changes determined by the chemistry available to the
side chain in a defined environment. At the same time the
evolutionary selection pressure may work on other levels to con-
serve protein function. Selection pressure on IDPRs may also
work at the biophysical level and to keep a balance between
retaining an ability to form a defined structure in the pres-
ence of another protein or a metabolite or slipping into a
state that cannot be ordered. It could therefore be beneficial
to preserve the disorder to prevent order—that is to prevent
the formation of secondary structural elements that would hin-
der the recognition process. We believe there must be such
selection pressure to keep the disorder, to prevent the energet-
ically favorable secondary or tertiary structures from forming
and thus prevent or induce biological function, and that this
is preserved in the fingerprint region. To study this, the exper-
imental approach must be designed to accommodate the spe-
cific biophysical characteristics of IDPRs. A common approach
to probe protein function is by mutation of key residues—
often to alanine to remove amino acid side chain properties.
However, in the case of IDPRs one should consider the propen-
sity of alanine to form α-helices when designing a mutational
experiment.
The SLC4 family of membrane transporters has proven to
be a challenging group of proteins to target for structural and
biophysical studies. We hope to elucidate biophysical properties
of this group of proteins in order to target individual members
selectively with novel inhibitors. The development of these could
greatly benefit the field and become valuable tools for further
in vivo investigations.
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